0
  • Category
  • Region
U.S. (TOLL FREE)
+1 (315) 215-3225
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Human Serum Albumin Market Research Report 2025
Published Date: March 2025
|
Report Code: QYRE-Auto-13S8713
Home | Market Reports | Health| Nursing
Global Human Serum Albumin Market Insights and Forecast to 2028
BUY CHAPTERS

Global Human Serum Albumin Market Research Report 2025

Code: QYRE-Auto-13S8713
Report
March 2025
Pages:97
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Human Serum Albumin Market Size

The global market for Human Serum Albumin was valued at US$ 6375 million in the year 2024 and is projected to reach a revised size of US$ 9817 million by 2031, growing at a CAGR of 6.5% during the forecast period.

Human Serum Albumin Market

Human Serum Albumin Market

Human Serum Albumin is a water-soluble globular protein produced in the liver. It accounts for 50% of blood plasma proteins. These play a vital role in regulating blood volume and act as transporters for molecules such as few hormones, bile salts, and ions. Albumin is commonly used as blood volumizer in rare diseases, burns, shocks, liver conditions, and other blood loss trauma and surgeries.
The human serum albumin (HSA) market is driven by the increasing prevalence of liver diseases, nephrotic syndrome, and hypoalbuminemia, which require albumin-based therapies. Additionally, HSA is widely used in critical care settings for treating burns, shock, and surgical recovery, boosting its demand. The expanding applications of albumin in biopharmaceuticals, including drug delivery, vaccine formulation, and regenerative medicine, further fuel market growth. Rising healthcare expenditures, improvements in plasma collection infrastructure, and growing demand in emerging markets like China and India contribute to the industry's expansion.
However, the market faces challenges such as limited plasma supply and high production costs, as HSA is primarily derived from human plasma, which is subject to stringent donation regulations. Stringent government policies and safety concerns regarding pathogen transmission also hinder market growth. Additionally, competition from synthetic and recombinant HSA (rHSA) is increasing, though high production costs and market acceptance remain barriers. Overcoming supply chain constraints and advancing rHSA technologies will be crucial for sustaining growth in the global HSA market.
The key global producers of human serum albumin are Grifols, CSL, Takeda, Octapharma, CBPO, Hualan Bio, Kedrio, and Shanghai RAAS, with the top four manufacturers together holding 60% of the market share. The largest producer is CSL with a market share of 21.25%. In terms of consumption level, the market is mainly distributed in North America, Europe and Asia Pacific, with Asia Pacific having the highest market share of 68.63%.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Human Serum Albumin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Serum Albumin.
The Human Serum Albumin market size, estimations, and forecasts are provided in terms of sales volume (MT) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Human Serum Albumin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Human Serum Albumin manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Human Serum Albumin Market Report

Report Metric Details
Report Name Human Serum Albumin Market
Accounted market size in year US$ 6375 million
Forecasted market size in 2031 US$ 9817 million
CAGR 6.5%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • 20-25% Concentrations
  • 5% Concentrations
Segment by Application
  • Therapeutics
  • Excipient
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Grifols, CSL, Takeda, Octapharma, CBPO, Hualan Bio, Kedrion, Shanghai RAAS, LFB Group, Weiguang Bio, Tiantan Bio, Shuanglin Bio, Boya Bio, Yuanda Shuyang
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Human Serum Albumin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Human Serum Albumin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Human Serum Albumin Market growing?

Ans: The Human Serum Albumin Market witnessing a CAGR of 6.5% during the forecast period 2025-2031.

What is the Human Serum Albumin Market size in 2031?

Ans: The Human Serum Albumin Market size in 2031 will be US$ 9817 million.

What is the market share of major companies in Human Serum Albumin Market?

Ans: The key global producers of human serum albumin are Grifols, CSL, Takeda, Octapharma, CBPO, Hualan Bio, Kedrio, and Shanghai RAAS, with the top four manufacturers together holding 60% of the market share.

What is the CSL share in Human Serum Albumin Market?

Ans: The largest producer is CSL with a market share of 21.25%.

Who are the main players in the Human Serum Albumin Market report?

Ans: The main players in the Human Serum Albumin Market are Grifols, CSL, Takeda, Octapharma, CBPO, Hualan Bio, Kedrion, Shanghai RAAS, LFB Group, Weiguang Bio, Tiantan Bio, Shuanglin Bio, Boya Bio, Yuanda Shuyang

What are the Application segmentation covered in the Human Serum Albumin Market report?

Ans: The Applications covered in the Human Serum Albumin Market report are Therapeutics, Excipient, Other

What are the Type segmentation covered in the Human Serum Albumin Market report?

Ans: The Types covered in the Human Serum Albumin Market report are 20-25% Concentrations, 5% Concentrations

1 Human Serum Albumin Market Overview
1.1 Product Definition
1.2 Human Serum Albumin by Type
1.2.1 Global Human Serum Albumin Market Value Comparison by Type (2024 VS 2031)
1.2.2 20-25% Concentrations
1.2.3 5% Concentrations
1.3 Human Serum Albumin by Application
1.3.1 Global Human Serum Albumin Market Value by Application (2024 VS 2031)
1.3.2 Therapeutics
1.3.3 Excipient
1.3.4 Other
1.4 Global Human Serum Albumin Market Size Estimates and Forecasts
1.4.1 Global Human Serum Albumin Revenue 2020-2031
1.4.2 Global Human Serum Albumin Sales 2020-2031
1.4.3 Global Human Serum Albumin Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Human Serum Albumin Market Competition by Manufacturers
2.1 Global Human Serum Albumin Sales Market Share by Manufacturers (2020-2025)
2.2 Global Human Serum Albumin Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Human Serum Albumin Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Human Serum Albumin, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Human Serum Albumin, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Human Serum Albumin, Product Type & Application
2.7 Global Key Manufacturers of Human Serum Albumin, Date of Enter into This Industry
2.8 Global Human Serum Albumin Market Competitive Situation and Trends
2.8.1 Global Human Serum Albumin Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Human Serum Albumin Players Market Share by Revenue
2.8.3 Global Human Serum Albumin Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Human Serum Albumin Market Scenario by Region
3.1 Global Human Serum Albumin Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Human Serum Albumin Sales by Region: 2020-2031
3.2.1 Global Human Serum Albumin Sales by Region: 2020-2025
3.2.2 Global Human Serum Albumin Sales by Region: 2026-2031
3.3 Global Human Serum Albumin Revenue by Region: 2020-2031
3.3.1 Global Human Serum Albumin Revenue by Region: 2020-2025
3.3.2 Global Human Serum Albumin Revenue by Region: 2026-2031
3.4 North America Human Serum Albumin Market Facts & Figures by Country
3.4.1 North America Human Serum Albumin Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Human Serum Albumin Sales by Country (2020-2031)
3.4.3 North America Human Serum Albumin Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Human Serum Albumin Market Facts & Figures by Country
3.5.1 Europe Human Serum Albumin Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Human Serum Albumin Sales by Country (2020-2031)
3.5.3 Europe Human Serum Albumin Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Human Serum Albumin Market Facts & Figures by Region
3.6.1 Asia Pacific Human Serum Albumin Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Human Serum Albumin Sales by Region (2020-2031)
3.6.3 Asia Pacific Human Serum Albumin Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Human Serum Albumin Market Facts & Figures by Country
3.7.1 Latin America Human Serum Albumin Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Human Serum Albumin Sales by Country (2020-2031)
3.7.3 Latin America Human Serum Albumin Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Human Serum Albumin Market Facts & Figures by Country
3.8.1 Middle East and Africa Human Serum Albumin Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Human Serum Albumin Sales by Country (2020-2031)
3.8.3 Middle East and Africa Human Serum Albumin Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Human Serum Albumin Sales by Type (2020-2031)
4.1.1 Global Human Serum Albumin Sales by Type (2020-2025)
4.1.2 Global Human Serum Albumin Sales by Type (2026-2031)
4.1.3 Global Human Serum Albumin Sales Market Share by Type (2020-2031)
4.2 Global Human Serum Albumin Revenue by Type (2020-2031)
4.2.1 Global Human Serum Albumin Revenue by Type (2020-2025)
4.2.2 Global Human Serum Albumin Revenue by Type (2026-2031)
4.2.3 Global Human Serum Albumin Revenue Market Share by Type (2020-2031)
4.3 Global Human Serum Albumin Price by Type (2020-2031)
5 Segment by Application
5.1 Global Human Serum Albumin Sales by Application (2020-2031)
5.1.1 Global Human Serum Albumin Sales by Application (2020-2025)
5.1.2 Global Human Serum Albumin Sales by Application (2026-2031)
5.1.3 Global Human Serum Albumin Sales Market Share by Application (2020-2031)
5.2 Global Human Serum Albumin Revenue by Application (2020-2031)
5.2.1 Global Human Serum Albumin Revenue by Application (2020-2025)
5.2.2 Global Human Serum Albumin Revenue by Application (2026-2031)
5.2.3 Global Human Serum Albumin Revenue Market Share by Application (2020-2031)
5.3 Global Human Serum Albumin Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Grifols
6.1.1 Grifols Company Information
6.1.2 Grifols Description and Business Overview
6.1.3 Grifols Human Serum Albumin Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Grifols Human Serum Albumin Product Portfolio
6.1.5 Grifols Recent Developments/Updates
6.2 CSL
6.2.1 CSL Company Information
6.2.2 CSL Description and Business Overview
6.2.3 CSL Human Serum Albumin Sales, Revenue and Gross Margin (2020-2025)
6.2.4 CSL Human Serum Albumin Product Portfolio
6.2.5 CSL Recent Developments/Updates
6.3 Takeda
6.3.1 Takeda Company Information
6.3.2 Takeda Description and Business Overview
6.3.3 Takeda Human Serum Albumin Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Takeda Human Serum Albumin Product Portfolio
6.3.5 Takeda Recent Developments/Updates
6.4 Octapharma
6.4.1 Octapharma Company Information
6.4.2 Octapharma Description and Business Overview
6.4.3 Octapharma Human Serum Albumin Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Octapharma Human Serum Albumin Product Portfolio
6.4.5 Octapharma Recent Developments/Updates
6.5 CBPO
6.5.1 CBPO Company Information
6.5.2 CBPO Description and Business Overview
6.5.3 CBPO Human Serum Albumin Sales, Revenue and Gross Margin (2020-2025)
6.5.4 CBPO Human Serum Albumin Product Portfolio
6.5.5 CBPO Recent Developments/Updates
6.6 Hualan Bio
6.6.1 Hualan Bio Company Information
6.6.2 Hualan Bio Description and Business Overview
6.6.3 Hualan Bio Human Serum Albumin Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Hualan Bio Human Serum Albumin Product Portfolio
6.6.5 Hualan Bio Recent Developments/Updates
6.7 Kedrion
6.7.1 Kedrion Company Information
6.7.2 Kedrion Description and Business Overview
6.7.3 Kedrion Human Serum Albumin Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Kedrion Human Serum Albumin Product Portfolio
6.7.5 Kedrion Recent Developments/Updates
6.8 Shanghai RAAS
6.8.1 Shanghai RAAS Company Information
6.8.2 Shanghai RAAS Description and Business Overview
6.8.3 Shanghai RAAS Human Serum Albumin Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Shanghai RAAS Human Serum Albumin Product Portfolio
6.8.5 Shanghai RAAS Recent Developments/Updates
6.9 LFB Group
6.9.1 LFB Group Company Information
6.9.2 LFB Group Description and Business Overview
6.9.3 LFB Group Human Serum Albumin Sales, Revenue and Gross Margin (2020-2025)
6.9.4 LFB Group Human Serum Albumin Product Portfolio
6.9.5 LFB Group Recent Developments/Updates
6.10 Weiguang Bio
6.10.1 Weiguang Bio Company Information
6.10.2 Weiguang Bio Description and Business Overview
6.10.3 Weiguang Bio Human Serum Albumin Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Weiguang Bio Human Serum Albumin Product Portfolio
6.10.5 Weiguang Bio Recent Developments/Updates
6.11 Tiantan Bio
6.11.1 Tiantan Bio Company Information
6.11.2 Tiantan Bio Description and Business Overview
6.11.3 Tiantan Bio Human Serum Albumin Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Tiantan Bio Human Serum Albumin Product Portfolio
6.11.5 Tiantan Bio Recent Developments/Updates
6.12 Shuanglin Bio
6.12.1 Shuanglin Bio Company Information
6.12.2 Shuanglin Bio Description and Business Overview
6.12.3 Shuanglin Bio Human Serum Albumin Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Shuanglin Bio Human Serum Albumin Product Portfolio
6.12.5 Shuanglin Bio Recent Developments/Updates
6.13 Boya Bio
6.13.1 Boya Bio Company Information
6.13.2 Boya Bio Description and Business Overview
6.13.3 Boya Bio Human Serum Albumin Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Boya Bio Human Serum Albumin Product Portfolio
6.13.5 Boya Bio Recent Developments/Updates
6.14 Yuanda Shuyang
6.14.1 Yuanda Shuyang Company Information
6.14.2 Yuanda Shuyang Description and Business Overview
6.14.3 Yuanda Shuyang Human Serum Albumin Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Yuanda Shuyang Human Serum Albumin Product Portfolio
6.14.5 Yuanda Shuyang Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Human Serum Albumin Industry Chain Analysis
7.2 Human Serum Albumin Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Human Serum Albumin Production Mode & Process Analysis
7.4 Human Serum Albumin Sales and Marketing
7.4.1 Human Serum Albumin Sales Channels
7.4.2 Human Serum Albumin Distributors
7.5 Human Serum Albumin Customer Analysis
8 Human Serum Albumin Market Dynamics
8.1 Human Serum Albumin Industry Trends
8.2 Human Serum Albumin Market Drivers
8.3 Human Serum Albumin Market Challenges
8.4 Human Serum Albumin Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Human Serum Albumin Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Human Serum Albumin Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Human Serum Albumin Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Human Serum Albumin Sales (MT) of Key Manufacturers (2020-2025)
 Table 5. Global Human Serum Albumin Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Human Serum Albumin Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Human Serum Albumin Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Human Serum Albumin Average Price (US$/Kg) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Human Serum Albumin, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Human Serum Albumin, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Human Serum Albumin, Product Type & Application
 Table 12. Global Key Manufacturers of Human Serum Albumin, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Human Serum Albumin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Serum Albumin as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Human Serum Albumin Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Human Serum Albumin Sales by Region (2020-2025) & (MT)
 Table 18. Global Human Serum Albumin Sales Market Share by Region (2020-2025)
 Table 19. Global Human Serum Albumin Sales by Region (2026-2031) & (MT)
 Table 20. Global Human Serum Albumin Sales Market Share by Region (2026-2031)
 Table 21. Global Human Serum Albumin Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Human Serum Albumin Revenue Market Share by Region (2020-2025)
 Table 23. Global Human Serum Albumin Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Human Serum Albumin Revenue Market Share by Region (2026-2031)
 Table 25. North America Human Serum Albumin Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Human Serum Albumin Sales by Country (2020-2025) & (MT)
 Table 27. North America Human Serum Albumin Sales by Country (2026-2031) & (MT)
 Table 28. North America Human Serum Albumin Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Human Serum Albumin Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Human Serum Albumin Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Human Serum Albumin Sales by Country (2020-2025) & (MT)
 Table 32. Europe Human Serum Albumin Sales by Country (2026-2031) & (MT)
 Table 33. Europe Human Serum Albumin Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Human Serum Albumin Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Human Serum Albumin Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Human Serum Albumin Sales by Region (2020-2025) & (MT)
 Table 37. Asia Pacific Human Serum Albumin Sales by Region (2026-2031) & (MT)
 Table 38. Asia Pacific Human Serum Albumin Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Human Serum Albumin Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Human Serum Albumin Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Human Serum Albumin Sales by Country (2020-2025) & (MT)
 Table 42. Latin America Human Serum Albumin Sales by Country (2026-2031) & (MT)
 Table 43. Latin America Human Serum Albumin Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Human Serum Albumin Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Human Serum Albumin Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Human Serum Albumin Sales by Country (2020-2025) & (MT)
 Table 47. Middle East and Africa Human Serum Albumin Sales by Country (2026-2031) & (MT)
 Table 48. Middle East and Africa Human Serum Albumin Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Human Serum Albumin Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Human Serum Albumin Sales (MT) by Type (2020-2025)
 Table 51. Global Human Serum Albumin Sales (MT) by Type (2026-2031)
 Table 52. Global Human Serum Albumin Sales Market Share by Type (2020-2025)
 Table 53. Global Human Serum Albumin Sales Market Share by Type (2026-2031)
 Table 54. Global Human Serum Albumin Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Human Serum Albumin Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Human Serum Albumin Revenue Market Share by Type (2020-2025)
 Table 57. Global Human Serum Albumin Revenue Market Share by Type (2026-2031)
 Table 58. Global Human Serum Albumin Price (US$/Kg) by Type (2020-2025)
 Table 59. Global Human Serum Albumin Price (US$/Kg) by Type (2026-2031)
 Table 60. Global Human Serum Albumin Sales (MT) by Application (2020-2025)
 Table 61. Global Human Serum Albumin Sales (MT) by Application (2026-2031)
 Table 62. Global Human Serum Albumin Sales Market Share by Application (2020-2025)
 Table 63. Global Human Serum Albumin Sales Market Share by Application (2026-2031)
 Table 64. Global Human Serum Albumin Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Human Serum Albumin Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Human Serum Albumin Revenue Market Share by Application (2020-2025)
 Table 67. Global Human Serum Albumin Revenue Market Share by Application (2026-2031)
 Table 68. Global Human Serum Albumin Price (US$/Kg) by Application (2020-2025)
 Table 69. Global Human Serum Albumin Price (US$/Kg) by Application (2026-2031)
 Table 70. Grifols Company Information
 Table 71. Grifols Description and Business Overview
 Table 72. Grifols Human Serum Albumin Sales (MT), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 73. Grifols Human Serum Albumin Product
 Table 74. Grifols Recent Developments/Updates
 Table 75. CSL Company Information
 Table 76. CSL Description and Business Overview
 Table 77. CSL Human Serum Albumin Sales (MT), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 78. CSL Human Serum Albumin Product
 Table 79. CSL Recent Developments/Updates
 Table 80. Takeda Company Information
 Table 81. Takeda Description and Business Overview
 Table 82. Takeda Human Serum Albumin Sales (MT), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 83. Takeda Human Serum Albumin Product
 Table 84. Takeda Recent Developments/Updates
 Table 85. Octapharma Company Information
 Table 86. Octapharma Description and Business Overview
 Table 87. Octapharma Human Serum Albumin Sales (MT), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 88. Octapharma Human Serum Albumin Product
 Table 89. Octapharma Recent Developments/Updates
 Table 90. CBPO Company Information
 Table 91. CBPO Description and Business Overview
 Table 92. CBPO Human Serum Albumin Sales (MT), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 93. CBPO Human Serum Albumin Product
 Table 94. CBPO Recent Developments/Updates
 Table 95. Hualan Bio Company Information
 Table 96. Hualan Bio Description and Business Overview
 Table 97. Hualan Bio Human Serum Albumin Sales (MT), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 98. Hualan Bio Human Serum Albumin Product
 Table 99. Hualan Bio Recent Developments/Updates
 Table 100. Kedrion Company Information
 Table 101. Kedrion Description and Business Overview
 Table 102. Kedrion Human Serum Albumin Sales (MT), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 103. Kedrion Human Serum Albumin Product
 Table 104. Kedrion Recent Developments/Updates
 Table 105. Shanghai RAAS Company Information
 Table 106. Shanghai RAAS Description and Business Overview
 Table 107. Shanghai RAAS Human Serum Albumin Sales (MT), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 108. Shanghai RAAS Human Serum Albumin Product
 Table 109. Shanghai RAAS Recent Developments/Updates
 Table 110. LFB Group Company Information
 Table 111. LFB Group Description and Business Overview
 Table 112. LFB Group Human Serum Albumin Sales (MT), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 113. LFB Group Human Serum Albumin Product
 Table 114. LFB Group Recent Developments/Updates
 Table 115. Weiguang Bio Company Information
 Table 116. Weiguang Bio Description and Business Overview
 Table 117. Weiguang Bio Human Serum Albumin Sales (MT), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 118. Weiguang Bio Human Serum Albumin Product
 Table 119. Weiguang Bio Recent Developments/Updates
 Table 120. Tiantan Bio Company Information
 Table 121. Tiantan Bio Description and Business Overview
 Table 122. Tiantan Bio Human Serum Albumin Sales (MT), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 123. Tiantan Bio Human Serum Albumin Product
 Table 124. Tiantan Bio Recent Developments/Updates
 Table 125. Shuanglin Bio Company Information
 Table 126. Shuanglin Bio Description and Business Overview
 Table 127. Shuanglin Bio Human Serum Albumin Sales (MT), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 128. Shuanglin Bio Human Serum Albumin Product
 Table 129. Shuanglin Bio Recent Developments/Updates
 Table 130. Boya Bio Company Information
 Table 131. Boya Bio Description and Business Overview
 Table 132. Boya Bio Human Serum Albumin Sales (MT), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 133. Boya Bio Human Serum Albumin Product
 Table 134. Boya Bio Recent Developments/Updates
 Table 135. Yuanda Shuyang Company Information
 Table 136. Yuanda Shuyang Description and Business Overview
 Table 137. Yuanda Shuyang Human Serum Albumin Sales (MT), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 138. Yuanda Shuyang Human Serum Albumin Product
 Table 139. Yuanda Shuyang Recent Developments/Updates
 Table 140. Key Raw Materials Lists
 Table 141. Raw Materials Key Suppliers Lists
 Table 142. Human Serum Albumin Distributors List
 Table 143. Human Serum Albumin Customers List
 Table 144. Human Serum Albumin Market Trends
 Table 145. Human Serum Albumin Market Drivers
 Table 146. Human Serum Albumin Market Challenges
 Table 147. Human Serum Albumin Market Restraints
 Table 148. Research Programs/Design for This Report
 Table 149. Key Data Information from Secondary Sources
 Table 150. Key Data Information from Primary Sources
 Table 151. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Human Serum Albumin
 Figure 2. Global Human Serum Albumin Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Human Serum Albumin Market Share by Type: 2024 & 2031
 Figure 4. 20-25% Concentrations Product Picture
 Figure 5. 5% Concentrations Product Picture
 Figure 6. Global Human Serum Albumin Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Human Serum Albumin Market Share by Application: 2024 & 2031
 Figure 8. Therapeutics
 Figure 9. Excipient
 Figure 10. Other
 Figure 11. Global Human Serum Albumin Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Human Serum Albumin Market Size (2020-2031) & (US$ Million)
 Figure 13. Global Human Serum Albumin Sales (2020-2031) & (MT)
 Figure 14. Global Human Serum Albumin Average Price (US$/Kg) & (2020-2031)
 Figure 15. Human Serum Albumin Report Years Considered
 Figure 16. Human Serum Albumin Sales Share by Manufacturers in 2024
 Figure 17. Global Human Serum Albumin Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest Human Serum Albumin Players: Market Share by Revenue in Human Serum Albumin in 2024
 Figure 19. Human Serum Albumin Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global Human Serum Albumin Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America Human Serum Albumin Sales Market Share by Country (2020-2031)
 Figure 22. North America Human Serum Albumin Revenue Market Share by Country (2020-2031)
 Figure 23. United States Human Serum Albumin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada Human Serum Albumin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe Human Serum Albumin Sales Market Share by Country (2020-2031)
 Figure 26. Europe Human Serum Albumin Revenue Market Share by Country (2020-2031)
 Figure 27. Germany Human Serum Albumin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France Human Serum Albumin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. Human Serum Albumin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy Human Serum Albumin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia Human Serum Albumin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific Human Serum Albumin Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific Human Serum Albumin Revenue Market Share by Region (2020-2031)
 Figure 34. China Human Serum Albumin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan Human Serum Albumin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea Human Serum Albumin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India Human Serum Albumin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia Human Serum Albumin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. China Taiwan Human Serum Albumin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Southeast Asia Human Serum Albumin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Latin America Human Serum Albumin Sales Market Share by Country (2020-2031)
 Figure 42. Latin America Human Serum Albumin Revenue Market Share by Country (2020-2031)
 Figure 43. Mexico Human Serum Albumin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Brazil Human Serum Albumin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Argentina Human Serum Albumin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Middle East and Africa Human Serum Albumin Sales Market Share by Country (2020-2031)
 Figure 47. Middle East and Africa Human Serum Albumin Revenue Market Share by Country (2020-2031)
 Figure 48. Turkey Human Serum Albumin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Saudi Arabia Human Serum Albumin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. UAE Human Serum Albumin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Global Sales Market Share of Human Serum Albumin by Type (2020-2031)
 Figure 52. Global Revenue Market Share of Human Serum Albumin by Type (2020-2031)
 Figure 53. Global Human Serum Albumin Price (US$/Kg) by Type (2020-2031)
 Figure 54. Global Sales Market Share of Human Serum Albumin by Application (2020-2031)
 Figure 55. Global Revenue Market Share of Human Serum Albumin by Application (2020-2031)
 Figure 56. Global Human Serum Albumin Price (US$/Kg) by Application (2020-2031)
 Figure 57. Human Serum Albumin Value Chain
 Figure 58. Channels of Distribution (Direct Vs Distribution)
 Figure 59. Bottom-up and Top-down Approaches for This Report
 Figure 60. Data Triangulation
 Figure 61. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SecuX Technology Inc

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global CGT CDMO Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34J6684
Fri Mar 14 00:00:00 UTC 2025

Add to Cart

Global Minimal Residual Disease (MRD) Dynamic Monitor Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3A15503
Thu Mar 13 00:00:00 UTC 2025

Add to Cart

Global Independent Clinical Laboratory (ICL) Service Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-10U15290
Thu Mar 13 00:00:00 UTC 2025

Add to Cart

Global Boron Neutron Capture Therapy (BNCT) Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-11S15473
Thu Mar 13 00:00:00 UTC 2025

Add to Cart